Regulation of Ion Homeostasis for Enhanced Tumor Radio‐Immunotherapy
Advanced Science · 2023
DOI: 10.1002/advs.202304092 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, 2023. Verfasst von Rui Qian und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Surgery and Guangdong Provincial Key Laboratory of Precision Medicine for Gastrointestinal Tumor, Nanfang Hospital, The First S…. Hauptthemen laut MEDLINE: Calcium, Neoplasms. Die Arbeit wurde bisher 45-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Key Research and Development Program of Social Development of Jiangsu Province, Priority Academic Program Development of Jiangsu Higher Education Institutions.
Abstract (Originalsprache)
Intra/extracellular ion content affects the growth and metastasis of tumor cells, as well as the efficacy of various antitumor therapies. Herein, a carbonic anhydrase inhibitor (CAI) is loaded onto pH‐responsive calcium carbonate (CaCO 3 ) nanoparticles and then modify theses nanoparticles with liposomes to obtain biocompatible CaCO 3 /CAI@Lipsome (CCL) for enhance tumor radio‐immunotherapy. CCL can specially decompose in tumor microenvironment, releasing calcium ion (Ca 2+ ) and CAI, as well as increasing the pH value of extracellular fluid. CAI restrains the flow of hydrogen ion (H + ) inside and outside the tumor cells, resulting in the reversal of tumor acidic microenvironment and the increase of intracellular H + , both of which can improve the sensitivity of tumor to radiotherapy. Afterward, the increased intracellular H + together with radiotherapy‐causes reactive oxygen species promotes calcium influx, leading to cellular calcium overload. Moreover, the CCL‐tailored content of H + and Ca 2+ strengthens radiotherapy‐induced immunogenic cell death and dendritic cell maturation, amplifying systemic anti‐tumor adaptive immunity. Meanwhile, macrophages in the CCL‐treated tumors are polarized from pro‐tumor M2 to anti‐tumor M1 under X‐ray exposure, owing to the neutralization of tumor acidic microenvironment and enhances Ca 2+ content. Therefore, multi‐directional regulation of the intra/extra tumor cell pH/calcium by simple nano‐preparation would provide a powerful way to improve the efficacy of radio‐immunotherapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of General Surgery and Guangdong Provincial Key Laboratory of Precision Medicine for Gastrointestinal Tumor, Nanfang Hospital, The First School of Clinical Medicine, Southern Medical University, Guangzhou, 51…
- School of Pharmacy, Jiangsu Key Laboratory of Inflammation and Molecular Drug Targets, Nantong University, Nantong, Jiangsu, 226001, China.
- State Key Laboratory of Radiation Medicine and Protection, School of Radiation Medicine and Protection and School for Radiological and Interdisciplinary Sciences (RAD-X), Collaborative Innovation Center of Radiation Med…
- Department of Pathology, The First Affiliated Hospital of Soochow University, Soochow University, Suzhou, 215005, China.
ORCID-Profile: Kai Yang
Förderung
- National Natural Science Foundation of China
- Key Research and Development Program of Social Development of Jiangsu Province
- Priority Academic Program Development of Jiangsu Higher Education Institutions
Zitieren
APA
Qian, R., Yi, X., Liu, T., Chen, H., Wang, Y., Hu, L., Guo, L., Yang, K., & Deng, H. (2023). Regulation of Ion Homeostasis for Enhanced Tumor Radio‐Immunotherapy. Advanced Science. https://doi.org/10.1002/advs.202304092
Vancouver
Qian R, Yi X, Liu T, Chen H, Wang Y, Hu L, et al. Regulation of Ion Homeostasis for Enhanced Tumor Radio‐Immunotherapy. Advanced Science. 2023. doi:10.1002/advs.202304092
BibTeX
@article{Qian2023,
author = {Qian, Rui and Yi, Xuan and Liu, Teng and Chen, Hua and Wang, Yuhong and Hu, Lin and Guo, Lingchuan and Yang, Kai and Deng, Haijun},
title = {Regulation of Ion Homeostasis for Enhanced Tumor Radio‐Immunotherapy},
journal = {Advanced Science},
year = {2023},
doi = {10.1002/advs.202304092}
}
EUVIMED